Tetrazine 25 Tablet contains Tetrabenazine 25mg, a dopamine-depleting agent used for the management of movement disorders. It helps in reducing symptoms such as involuntary movements, tics, and abnormal motor activity commonly seen in conditions like Huntington’s disease, hemiballismus, chorea, and tardive dyskinesia.
Tetrabenazine works by decreasing dopamine activity in the brain, helping to control excessive or uncontrolled body movements. It belongs to the neurology and CNS therapeutic segment, and is commonly prescribed by neurologists for symptomatic relief in hyperkinetic disorders.
Tetrazine 25 Tablet is widely demanded in hospitals, neuro clinics, and rehabilitation centers due to its essential role in neurological treatment care.
Available for PCD pharma franchise, bulk distribution, institutional supply, and third-party manufacturing, Tetrazine 25 is a high‑value specialty CNS medicine with consistent prescription demand and strong market potential.